Central Nucleus Amygdala Neurons

Central Nucleus Amygdala Neurons

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Central Nucleus Amygdala Neurons</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Cell Types</td>
</tr>
<tr>
<td class="label">Brain Region</td>
<td>Amygdala, Central Nucleus</td>
</tr>
<tr>
<td class="label">Neuron Type</td>
<td>GABAergic Projection Neurons</td>
</tr>
<tr>
<td class="label">Primary Neurotransmitter</td>
<td>GABA</td>
</tr>
<tr>
<td class="label">Species</td>
<td>Human, Mouse, Rat</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000878](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000878)</td>
</tr>
<tr>
<td class="label">Marker</td>
<td>Function</td>
</tr>
<tr>
<td class="label">CRH</td>
<td>Stress response</td>
</tr>
<tr>
<td class="label">SST</td>
<td>Inhibitory modulation</td>
</tr>
<tr>
<td class="label">PKCδ</td>
<td>Fear conditioning</td>
</tr>
<tr>
<td class="label">NPY</td>
<td>Anxiety reduction</td>
</tr>
<tr>
<td class="label">PENK</td>
<td>Pain modulation</td>
</tr>
<tr>
<td class="label">Source</td>
<td>Signal Type</td>
</tr>
<tr>
<td class="label">Basolateral Amygdala</td>
<td>Glutamatergic</td>
</tr>
<tr>
<td class="label">Parabrachial Nucleus</td>
<td>Glutamatergic</td>
</tr>
<tr>

Central Nucleus Amygdala Neurons

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Central Nucleus Amygdala Neurons</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Cell Types</td>
</tr>
<tr>
<td class="label">Brain Region</td>
<td>Amygdala, Central Nucleus</td>
</tr>
<tr>
<td class="label">Neuron Type</td>
<td>GABAergic Projection Neurons</td>
</tr>
<tr>
<td class="label">Primary Neurotransmitter</td>
<td>GABA</td>
</tr>
<tr>
<td class="label">Species</td>
<td>Human, Mouse, Rat</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000878](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000878)</td>
</tr>
<tr>
<td class="label">Marker</td>
<td>Function</td>
</tr>
<tr>
<td class="label">CRH</td>
<td>Stress response</td>
</tr>
<tr>
<td class="label">SST</td>
<td>Inhibitory modulation</td>
</tr>
<tr>
<td class="label">PKCδ</td>
<td>Fear conditioning</td>
</tr>
<tr>
<td class="label">NPY</td>
<td>Anxiety reduction</td>
</tr>
<tr>
<td class="label">PENK</td>
<td>Pain modulation</td>
</tr>
<tr>
<td class="label">Source</td>
<td>Signal Type</td>
</tr>
<tr>
<td class="label">Basolateral Amygdala</td>
<td>Glutamatergic</td>
</tr>
<tr>
<td class="label">Parabrachial Nucleus</td>
<td>Glutamatergic</td>
</tr>
<tr>
<td class="label">Hypothalamus</td>
<td>GABAergic/Peptidergic</td>
</tr>
<tr>
<td class="label">Thalamus ( medial )</td>
<td>Glutamatergic</td>
</tr>
<tr>
<td class="label">Prefrontal Cortex</td>
<td>Glutamatergic</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>Glutamatergic</td>
</tr>
<tr>
<td class="label">Brainstem nuclei</td>
<td>Mixed</td>
</tr>
<tr>
<td class="label">Target</td>
<td>Signal Type</td>
</tr>
<tr>
<td class="label">Paraventricular Hypothalamus</td>
<td>CRH, GABA</td>
</tr>
<tr>
<td class="label">Lateral Hypothalamus</td>
<td>GABA</td>
</tr>
<tr>
<td class="label">Periaqueductal Gray</td>
<td>GABA</td>
</tr>
<tr>
<td class="label">Nucleus Tractus Solitarius</td>
<td>GABA</td>
</tr>
<tr>
<td class="label">Ventral Tegmental Area</td>
<td>GABA</td>
</tr>
<tr>
<td class="label">Locus Coeruleus</td>
<td>CRH</td>
</tr>
</table>

Central Nucleus Amygdala Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

The Central Nucleus of the Amygdala (CeA) is a critical杏仁核输出结构，位于杏仁核复合体的中央部位。作为大脑恐惧、焦虑和自主神经控制的核心调节中枢，CeA协调对威胁的生理和行为反应，并与多种神经退行性疾病的发生发展密切相关。 [@ledoux2007]

Overview

Multi-Taxonomy Classification

Taxonomy Database Cross-References

External Database Links

• [Cell Ontology (CL:0000878)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000878)
• [OBO Foundry (CL:0000878)](http://purl.obolibrary.org/obo/CL_0000878)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [Human Cell Atlas](https://www.humancellatlas.org/)

Anatomy and Precise Location

Spatial Organization

The Central Nucleus of the Amygdala is located in the medial portion of the amygdala complex, approximately 2.5-3.0 mm lateral to the midline and 8-9 mm ventral to the cortical surface in adult humans. In rodents, the CeA lies approximately 2.0-2.5 mm caudal to the bregma. [@etkin2007]

Subdivisions

The CeA is divided into three anatomically and functionally distinct divisions:

Boundaries

• Medial: Optic tract and tuberal hypothalamus
• Lateral: Basolateral amygdala (BLA)
• Dorsal: Stria terminalis and caudate nucleus
• Ventral: Entorhinal cortex and presubiculum

Morphology and Cellular Characteristics

Neuronal Types

GABAergic Projection Neurons (80-90%)

• Protein kinase C delta (PKCδ)-positive neurons: Fear conditioning circuits
• Somatostatin (SST)-positive neurons: Stress and anxiety modulation
• Corticotropin-releasing hormone (CRH)-positive neurons: HPA axis activation
• Proenkephalin (PENK)-positive neurons: Pain modulation

Neuropeptide Markers

Cellular Properties

• Soma size: Medium (15-25 μm diameter)
• Dendritic architecture: Spiny dendrites, moderate branching
• Axonal projections: Extensive to hypothalamus and brainstem
• Electrophysiology: Regular-spiking, some burst-firing

Molecular Mechanisms

Neurotransmitter Systems

GABAergic Signaling

• GABA synthesis: GAD67 (GAD1) and GAD65 (GAD2)
• GABA-A receptors: Fast inhibitory transmission
• GABA-B receptors: Modulatory effects
• Vesicular GABA transporter (VGAT)

Peptidergic Signaling

Corticotropin-Releasing Hormone (CRH)

• Released during stress
• Activates HPA axis
• Modulates anxiety and fear
• CRH receptor 1 (CRHR1) and CRHR2

• Inhibits growth hormone release
• Modulates neuronal excitability
• Anti-anxiety effects
• SSTR1-SSTR5 receptors

• Anxiolytic properties
• Reduces food intake
• Anti-epileptic effects
• Y1-Y5 receptors

Intracellular Signaling Pathways

Stress-Activated Pathways

• CRH → CRHR1 → cAMP/PKA: Anxiety behavior
• p38 MAPK: Stress-induced plasticity
• JNK: Neuronal apoptosis

Neuroplasticity Pathways

• ERK/MAPK: Long-term fear memory
• mTOR: Synaptic protein synthesis
• BDNF: Neuronal survival

Connectivity

Afferent Inputs

Efferent Outputs

Normal Function

Fear and Anxiety

Fear Conditioning

• Acquisition: Associations between neutral and aversive stimuli
• Expression: Freezing behavior and autonomic responses
• Extinction: Learning that stimuli are safe
• Generalization: Fear responses to similar stimuli

Anxiety Regulation

• Threat detection: Rapid processing of potential danger
• Risk assessment: Evaluation of environmental safety
• Stress response: Coordination of behavioral and physiological reactions
• Anxiety disorders: Dysregulated CeA activity

Autonomic Control

Cardiovascular Regulation

• Heart rate modulation via vagus
• Blood pressure regulation
• Baroreceptor reflex integration

Respiratory Control

• Breathing rate modulation
• Stress-induced hyperventilation
• Panic responses

Gastrointestinal Control

• Gastric motility regulation
• Stress-induced gastric ulceration
• Appetite suppression

Pain Modulation

Stress-Induced Analgesia

• Activation of endogenous opioid systems
• Descending inhibition pathways
• Interaction with PAG

Pain Facilitation

• Enhanced pain sensitivity in stress
• Chronic pain states
• Headaches and migraines

Reward and Motivation

Feeding Behavior

• Stress-induced anorexia
• Leptin and ghrelin interaction
• NPY modulation of appetite

Addiction

• Drug reward processing
• Withdrawal symptoms
• Relapse mechanisms

Disease Vulnerability

Alzheimer's Disease

Behavioral and Psychological Symptoms

• Anxiety: Present in 40-50% of AD patients
• Agitation: CeA dysfunction contributes
• Depression: Comorbid depression common

Autonomic Dysfunction

• Cardiovascular dysregulation: Orthostatic hypotension
• Sleep disturbances: Altered circadian rhythms
• GI dysfunction: Constipation, dysphagia

Pathological Mechanisms

• Amyloid deposition: In CeA neurons
• Tau pathology: Neurofibrillary tangles
• Cholinergic loss: Reduced acetylcholine
• CRH dysregulation: HPA axis hyperactivity

Parkinson's Disease

Non-Motor Symptoms

• Anxiety: 30-50% prevalence
• Depression: Up to 50% of patients
• Autonomic dysfunction: Orthostatic hypotension

Lewy Body Pathology

• α-Synuclein: Deposited in CeA
• Neuronal loss: Dopaminergic denervation
• Circuit dysfunction: Basal ganglia-amygdala circuits

Amyotrophic Lateral Sclerosis (ALS)

Psychiatric Comorbidities

• Anxiety: 20-30% prevalence
• Depression: Emotional lability
• Pseudobulbar affect: CeA involvement

Autonomic Failure

• Respiratory dysfunction: Leading cause of death
• Cardiovascular instability: Orthostatic hypotension
• Swallowing difficulties: Dysphagia

Depression and Anxiety Disorders

Major Depressive Disorder

• CRH hyperactivity: Elevated CRH in CeA
• SST deficits: Reduced somatostatin
• NPY reduction: Anxiety susceptibility

Anxiety Disorders

• Generalized anxiety: CeA hyperactivity
• Panic disorder: CeA fear circuits
• Phobias: Conditioned fear responses
• PTSD: Impaired extinction

Epilepsy

Temporal Lobe Epilepsy

• Seizure propagation: CeA as relay
• Fear memories: Affective components
• Autonomic seizures: Ictal symptoms

Therapeutic Implications

Pharmacological Approaches

Anxiolytics

• Benzodiazepines: GABA-A enhancement
• SSRIs/SNRIs: Serotonin modulation
• CRH antagonists: Stress reduction

Antidepressants

• TCAs: Broad neurotransmitter effects
• Ketamine: NMDA modulation
• SSRIs: Plasticity enhancement

Emerging Therapies

Deep Brain Stimulation

• Target: CeA or terminals
• Effects: Anxiety reduction
• Clinical trials: Ongoing

Gene Therapy

• CRH reduction: Viral vectors
• NPY enhancement: Anxiety treatment
• Optogenetic approaches: Circuit manipulation

Research Directions

Circuit Mapping

• Single-cell sequencing
• Viral tracing
• Optogenetic circuit analysis

Disease Mechanisms

• Animal models of neurodegeneration
• Biomarker development
• Therapeutic targets

Therapeutic Development

• Novel anxiolytics
• Neuromodulation approaches
• Cell replacement therapies
• Amygdala Overview
• Basolateral Amygdala Neurons
• Fear Conditioning Mechanisms
• Stress Response Pathways)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• Depression
• Anxiety Disorders

Background

The study of Central Nucleus Amygdala Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [Allen Brain Atlas - Amygdala](https://portal.brain-map.org/)
• [PubMed - Central Amygdala](https://pubmed.ncbi.nlm.nih.gov/?term=central+amygdala)
• [Neuroscience - Amygdala Circuits](https://www.neuroscience.org/)

References

calhoon2015, Resolving the neural circuits of anxiety (2015)
davis1992, The role of the amygdala in fear and anxiety (1992)
etkin2007, Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia (2007)
gilpin2015, The central amygdala as an integrative hub for anxiety and alcohol use disorders (2015)
janak2015, From circuits to behaviour in the amygdala (2015)
ledoux2007, The amygdala (2007)
pare2004, New vistas on amygdala networks and behavior (2004)
sehlmeyer2011, Neural correlates of trait anxiety in fear conditioning (2011)
shin2010, The neurocircuitry of fear, stress, and anxiety disorders (2010)
tovote2015, Tovote P, Fadok JP, Lüthi A. Neuronal circuits for fear and anxiety. Nat Rev Neurosci. 2015;16(6):317-331 (2015)

Pathway Diagram

The following diagram shows the key molecular relationships involving Central Nucleus Amygdala Neurons discovered through SciDEX knowledge graph analysis: